Abstract
Allergen immunotherapy (AIT) is an effective treatment option for patients with allergic rhinitis. The traditional build-up administration regimen consists of weekly to biweekly subcutaneous injections of allergens at increasing doses until a therapeutic or maintenance dose is reached. Six months of maintenance injections are typically needed to illustrate clinical improvement.1 Rush IT (RIT) features an accelerated build-up schedule that substantially shortens the time needed to reach maintenance dosing.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
